Christoph E Hagemeyer
Overview
Explore the profile of Christoph E Hagemeyer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
86
Citations
1364
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bass-Stringer S, Bernardo B, Yildiz G, Matsumoto A, Kiriazis H, Harmawan C, et al.
J Sport Health Sci
. 2025 Jan;
101023.
PMID: 39826614
Background: Elucidating mechanisms underlying atrial myopathy, which predisposes individuals to atrial fibrillation (AF), will be critical for preventing/treating AF. In a serendipitous discovery, we identified atrial enlargement, fibrosis, and thrombi...
2.
Roointan A, Xu R, Corrie S, Hagemeyer C, Alt K
J Am Soc Nephrol
. 2024 Dec;
36(3):500-518.
PMID: 39705082
The treatment and management of kidney diseases present a significant global challenge, affecting over 800 million individuals and necessitating innovative therapeutic strategies that transcend symptomatic relief. The application of nanotechnology...
3.
Wickramarachchi A, Shirejini S, Vatani A, Rana A, Khamooshi M, Seman M, et al.
ASAIO J
. 2024 Dec;
71(3):235-244.
PMID: 39698917
A critical factor in thrombus formation during venoarterial extracorporeal membrane oxygenation (VA ECMO) is prothrombotic flow dynamics generated by the drainage cannula's design. This study aimed to create and evaluate...
4.
Hashad R, Singla R, Bhangu S, Jap E, Zhu H, Peleg A, et al.
Ultrason Sonochem
. 2024 Apr;
105:106862.
PMID: 38580569
No abstract available.
5.
Niego B, Jupp B, Zia N, Xu R, Jap E, Ezeani M, et al.
Radiol Cardiothorac Imaging
. 2024 Mar;
6(2):e230098.
PMID: 38512024
Purpose To develop an approach for in vivo detection of interstitial cardiac fibrosis using PET with a peptide tracer targeting proteolyzed collagen IV (T-peptide). Materials and Methods T-peptide was conjugated...
6.
Loureiro L, Hoffmann L, Neuber C, Rupp L, Arndt C, Kegler A, et al.
J Exp Clin Cancer Res
. 2023 Dec;
42(1):341.
PMID: 38102692
Background: Chimeric antigen receptor (CAR) T-cells are a promising approach in cancer immunotherapy, particularly for treating hematologic malignancies. Yet, their effectiveness is limited when tackling solid tumors, where immune cell...
7.
Xu R, Jap E, Gubbins B, Hagemeyer C, Karas J
J Pept Sci
. 2023 Sep;
30(2):e3542.
PMID: 37697741
Insulin replacement therapy is essential for the management of diabetes. However, despite the relative success of this therapeutic strategy, there is still a need to improve glycaemic control and the...
8.
Xu R, Bhangu S, Sourris K, Vanni D, Sani M, Karas J, et al.
Adv Mater
. 2023 Mar;
35(21):e2210392.
PMID: 36908046
Glucose-responsive insulin-delivery platforms that are sensitive to dynamic glucose concentration fluctuations and provide both rapid and prolonged insulin release have great potential to control hyperglycemia and avoid hypoglycemia diabetes. Here,...
9.
Greening D, Xu R, Ale A, Hagemeyer C, Chen W
Semin Cancer Biol
. 2023 Feb;
90:73-100.
PMID: 36773820
Extracellular vesicles (EVs) function as a mode of intercellular communication and molecular transfer to elicit diverse biological/functional response. Accumulating evidence has highlighted that EVs from immune, tumour, stromal cells and...
10.
Shirejini S, Carberry J, McQuilten Z, Burrell A, Gregory S, Hagemeyer C
Thromb J
. 2023 Jan;
21(1):11.
PMID: 36703184
Extracorporeal membrane oxygenation (ECMO) can provide life-saving support for critically ill patients suffering severe respiratory and/or cardiac failure. However, thrombosis and bleeding remain common and complex problems to manage. Key...